Immunosuppressants - GI
Drug Safety Update
April 2014: There is an increased risk of tuberculosis, or reactivation of latent tuberculosis, during treatment with tumour necrosis factor alpha (TNF-alpha) inhibitors. TNF-alpha inhibitors are contraindicated in patients with active tuberculosis or other severe infections.
January 2015: Ustekinumab (Stelara): risk of exfoliative dermatitis
Pack | Price |
---|---|
2 pre-filled disposable injection | £704.28 |
Pack | Price |
---|---|
1 pre-filled disposable injection | £1,525.94 |
Pack | Price |
---|---|
1 vial | £2,147.00 |
Pack | Price |
---|---|
1 pre-filled disposable injection | £2,147.00 |